Newsroom

Venclose MAVEN Earns FDA Clearance to Treat Incompetent Perforator Veins

Venclose Corporate Overview Presentation Piper Sandler Healthcare Conference

Venclose to Participate in 2020 Piper Sandler Healthcare Conference

Venclose eclipses 2018 results, patient success

Vein Therapy News

Venclose brings in $27 million Series C to market venous reflux solution

MedCity News

Venclose Closes $27 Million Series C Funding

A New RF System: Venclose’s new radiofrequency technology outperforms legacy systems

Vein Therapy News

Venclose and Viant Partner to Deliver Next-Generation Vein Treatment Solutions

Venclose Completes Series B Financing and Announces the Appointment of Jeffrey G. Carr, MD as Chief Medical Officer and Gregory J. Vislocky to its Board of Directors

Venclose Celebrates 2,000th Procedure with Next-Generation Endovenous Radiofrequency Ablation System